Cancer Research

Targeting WSTF: New Hope for Chronic Inflammation Treatment
Research & Development Targeting WSTF: New Hope for Chronic Inflammation Treatment

Emerging research is offering new hope for millions suffering from chronic inflammation, a condition where the immune system's long-term response can damage healthy tissues. Identifying WSTF, a protein with a newly discovered role in chronic inflammation, has become a beacon for potential

Can AI Revolutionize Cancer Treatment Development?
Tech & Innovation Can AI Revolutionize Cancer Treatment Development?

What if the secret to faster and more effective cancer treatments isn't found in conventional laboratories but within the algorithms of artificial intelligence instead? Drug development has long been a drawn-out process, often taking over a decade to bring a new medication from concept to market.

Breastfeeding Lowers Breast Cancer Risk and Boosts Child Health
Research & Development Breastfeeding Lowers Breast Cancer Risk and Boosts Child Health

Breastfeeding has long been recognized not just as a timeless practice for nurturing infants but as a profound contributor to the health of both mothers and their children. In recent times, the spotlight has shifted toward breastfeeding's potential in reducing the risk of breast cancer and other

Is Ziihera a Game-Changer for HER2-Positive Biliary Cancer?
Management & Regulatory Is Ziihera a Game-Changer for HER2-Positive Biliary Cancer?

Introducing Ivan Kairatov, a biopharma expert renowned for his insights into pharmaceutical technology and innovation, particularly in research and development. Today, we're delving into a groundbreaking moment for biliary tract cancer treatment with the conditional approval of Jazz

Planned C-Sections Linked to Increased Risk of Childhood Leukemia
Research & Development Planned C-Sections Linked to Increased Risk of Childhood Leukemia

A new study centered around planned cesarean sections (C-sections) and their association with childhood leukemia sparks significant discussions. With rising rates of elective C-sections globally, healthcare professionals and policymakers are intrigued by findings suggesting heightened risks for

Gamma Knife Radiosurgery for Brain Metastases in Ovarian Cancer
Research & Development Gamma Knife Radiosurgery for Brain Metastases in Ovarian Cancer

In this engaging conversation with biopharma expert Ivan Kairatov, we delve into the complexities and innovations in treating brain metastases from ovarian cancer. Ivan shares insights from a recent study that evaluated the effectiveness of Gamma Knife Stereotactic Radiosurgery (GKSRS) in managing

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later